Tisagenlecleucel, up to 600 million car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
Short Description: Tisagenlecleucel car-pos t
Coverage Code: Carrier judgment
Action Code: No maintenance for this code
Date Added: January 1, 2019
Effective Date: January 1, 2019
Termination Date: